The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes

The V617F activating point mutation in Jak2 is associated with a proportion of myeloproliferative disorders. In normal hematopoietic cells, Jak2 signals only when associated with a growth factor receptor, such as the erythropoietin receptor (EpoR). We sought to identify the molecular requirements fo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wernig, Gerlinde, Gonneville, Jeffrey R., Crowley, Brian J., Rodrigues, Margret S., Reddy, Mamatha M., Hudon, Heidi E., Walz, Christoph, Reiter, Andreas, Podar, Klaus, Royer, Yohan, Constantinescu, Stefan N., Tomasson, Michael H., Griffin, James D., Gilliland, D. Gary, Sattler, Martin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2008
Gaiak:
Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2275031/
https://ncbi.nlm.nih.gov/pubmed/18216297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-07-102186
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak